Mottola Frank
SEC insider (Form 3/4/5 filer). CIK 0001804567. SVP, Chief Tech. Ops. Officer at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 54 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in ROCKVILLE, MD.
Companies Mottola Frank has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Officer, SVP, Chief Tech. Ops. Officer
Mottola Frank
CIK: 0001804567
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (54 total)
- Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect797 shares at avg. $46.57$37K - Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect1.7K shares- - Jul 29, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
1.7K shares- - Mar 9, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect1.6K shares at avg. $53.65$87K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.8K shares at avg. $54.73$98K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect3.8K shares- - Feb 28, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
3.8K shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Unit
1.9K shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect1.9K shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect977 shares at avg. $50.69$50K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 797 | $46.57 | $37,116 | Direct |
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 1,650 | - | $0 | Direct |
| Jul 29, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 1,650 | - | - | Direct |
| Mar 9, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 1,623 | $53.65 | $87,074 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,793 | $54.73 | $98,131 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 3,750 | - | $0 | Direct |
| Feb 28, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 3,750 | - | - | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Unit | 1,875 | - | - | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 1,875 | - | $0 | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 977 | $50.69 | $49,524 | Direct |
1-10 of 54 transactions